Skip to content

Envoy Medical COCH Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin-310.7%-26.2pp-262.7%-32.9pp-294.2%-99.6pp-262.2%-90.3pp-284.4%-136pp
Operating margin-9,881.2%-693pp-9,240.7%-682pp-9,824%-2,115pp-8,873%-2,302pp-9,188.7%-2,632pp
Net margin-9,875.6%-667pp-9,857.3%-615pp-10,475%-2,895pp-9,579.3%-5,093pp-9,209%-1,485pp
Efficiency
Asset turnover0.0×0.0×0.0×0.0×0.0×
Liquidity
Current ratio2.3×+1.2×0.5×-0.6×0.6×-0.1×0.9×+0.3×1.1×0.0×
Per Share
Book value per share$0.15+113%-$0.52+47.9%-$0.35+64.8%-$1.40-109%-$1.14-184%
Valuation
Market capitalization$61M+83.5%$19.13M-33.9%$18.47M-71.0%$30.28M-34.5%$27.68M-64.0%
Price / sales260.7×+111×79.4×-49.3×88.8×-140×136.4×-16.8×130.6×-128×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Envoy Medical's profit margins?
Envoy Medical (COCH) runs a -310.7% gross margin and a -9881.2% operating margin, with a -9875.6% net margin.
Where do Envoy Medical's ratios come from?
Every ratio is computed from Envoy Medical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.